(9Z)-Erythromycin A Oxime134931-01-4(3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-10-hydroxyimino-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one(9Z)-Erythromycin 9-OximeC37H68N2O13(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,Z)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one9-Erythromycin 9-OximeSCHEMBL8977511KYTWXIARANQMCA-PGYIPVOXSA-NKYTWXIARANQMCA-ZTILBQITSA-NAKOS015895597AE22799
Show more names
erythromycin A (Z)-oximeErythromycin A 9-(Z)-oximeErythromycin, 9-oxime, (9Z)-Erythromycin A 9-Oxime (Z-Isomer)Erythromycin A 9-Oxime/Erythromycin Oxime Z-Isomer/(3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-10-(hydroxyimino)-4-(((2R,4R,5S,6S)-5-hydroxy-4-meth
Properties
Computed structural properties
XLogP
3
Topological polar surface area
209 Ų
Hydrogen bond donors
6
Hydrogen bond acceptors
15
Rotatable bonds
7
Heavy atoms
52
Formal charge
0
Complexity
1,210
Physicochemical properties
Boiling point
841 · 841.0±65.0 °C(Predicted)
Density
1.28 · 1.28±0.1 g/cm3(Predicted)
solubility
Dichloromethane, Ethyl Acetate
pka
11.96 · 11.96±0.70(Predicted)
form
Powder
color
Light Yellow
Symbol(GHS)
9 · GHS09
Hazard statements
411 · H411
REACH Registrations
Active
Safety & regulation
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Safety data
Symbol(GHS)
GHS09
Hazard statements
H411
REACH Registrations
Active
Chemistry & industry
Applications
Uses(9Z)-Erythromycin A Oxime is a metabolite of Roxithromycin (R700850) in humans.